CODX vs ROL
Co-Diagnostics, Inc. Common Stock (CODX) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
CODX currently screens at market cap $31.4M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the CODX and ROL stock pages for the full models.
Not investment advice.